What are the risks and complication rates associated with an oesophagogastroduodenoscopy (OGDS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Risk of OGDS

Oesophagogastroduodenoscopy (OGDS/OGD) is a very safe procedure with an overall serious complication rate of approximately 0.1-0.15% for diagnostic procedures, though risks increase substantially with therapeutic interventions and in specific high-risk patient populations.

Major Complications and Mortality

The principal complications of diagnostic OGD include:

  • Perforation: 0.016-0.05% for diagnostic procedures 1, 2
  • Bleeding: Rare in diagnostic procedures; increases with therapeutic interventions
  • Pulmonary aspiration: Related to sedation and inadequate fasting
  • Cardiorespiratory events: Associated with sedation, particularly in elderly and ASA III-V patients 3
  • Death: Procedure-caused mortality is approximately 1 in 9,000 (0.01%) 4

All-cause 30-day mortality following OGD is approximately 4.4%, though the vast majority of these deaths are related to underlying patient conditions rather than the procedure itself 4. The procedure-contributed mortality rate is approximately 1 in 182 when considering cases where endoscopy may have accelerated death in critically ill patients 4.

Risk Stratification by Patient Population

High-Risk Groups

Elderly patients (≥65 years) experience approximately three times more complications than younger patients, including both gastrointestinal and non-gastrointestinal complications (cerebrovascular accident, acute myocardial infarction, congestive heart failure, and death) 5. However, OGD remains safe even in nonagenarians, with immediate complication rates of only 2.6% and similar 30-day mortality compared to octogenarians 6.

ASA grades III-V patients are at particular risk for adverse cardiorespiratory events, especially when receiving combined sedation and analgesia 3. The combination of benzodiazepines with opioids creates a synergistic (not merely additive) interaction that substantially increases cardiorespiratory risk 7.

Specific High-Risk Scenarios

Factors associated with increased mortality include 4:

  • Percutaneous endoscopic gastrostomy (PEG) insertion: Odds ratio 18.39
  • Melena or hematemesis indications: Odds ratio 9.01
  • Esophageal varices: Odds ratio 6.28

Sedation-Related Risks

The combination of topical anesthesia and intravenous sedation may increase aspiration risk 3. When combining benzodiazepines with opioids, doses must be reduced by up to fourfold, with the opioid administered first and benzodiazepine carefully titrated 7.

Oxygen desaturation occurs frequently during endoscopy, particularly with inexperienced endoscopists and in patients with chronic obstructive airways disease 7. Supplemental oxygen and pulse oximetry should be used routinely 3.

Operator Experience Impact

Endoscopists who have performed fewer than 500 diagnostic procedures are four times more likely to cause perforation than experienced colleagues 3. This underscores the critical importance of adequate training and supervision.

Special Populations Requiring Caution

Patients on Anticoagulation

Bleeding risk exists but is manageable with appropriate anticoagulation bridging protocols. Limited data suggest aspirin and NSAIDs do not significantly increase bleeding risk after diagnostic endoscopy 3.

Patients with Epidermolysis Bullosa

Diagnostic endoscopy is NOT recommended in EB patients due to risk of traumatizing fragile mucosa, causing new blister formation, scarring, and potentially life-threatening perforation 8. Radiological investigations (water-soluble contrast studies) are preferred.

Patients at Risk of Endocarditis

Antibiotic prophylaxis should be given to patients with prosthetic heart valves, previous endocarditis, synthetic vascular grafts <12 months old, systemic pulmonary shunts, and neutropenia 3.

Common Pitfalls to Avoid

  1. Inadequate fasting: Ensure 4-6 hours minimum; patients with achalasia may require prolonged fasting or esophageal lavage 3

  2. Excessive sedation in elderly/high-risk patients: Keep doses to minimum compatible with patient comfort 3

  3. Failure to recognize perforation: Suspect with persistent pain, breathlessness, fever, or tachycardia post-procedure. Transient chest pain is common, but persistent pain mandates chest X-ray and water-soluble contrast study 3

  4. Inadequate post-procedure monitoring: Continue monitoring into recovery period; ensure surgical support is available 3

Post-Procedure Safety Measures

Patients should be observed with regular vital signs monitoring. Before discharge, patients must:

  • Be tolerating oral fluids
  • Have stable vital signs
  • Receive written instructions to return immediately if pain, breathlessness, or fever develops 3

Routine chest X-ray and contrast studies are not essential post-procedure unless clinical suspicion of perforation exists 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.